• News
  • SAN DIEGO
  • BioTech

Polaris Group's drug to help treat pancreatic cancer

Polaris Group announced Monday that ADI-PEG 20, arginine deiminase formulated with polyethylene glycol, acts as a radiosensitizer of pancreatic cancer both in tissue culture and in mice with human pancreatic cancer.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!